This information was published on 2026-05-05T09:03:51 for IP Right Filed Published.
| Field | Value |
| (210) | 2649646 (IR 1913822) |
| (220) |
17 Mar 2026
|
| (300) |
US, 31 Dec 2025, 99573427
|
| (500) |
"THERAPEUTICS"
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of immune system related diseases and disorders, autoimmune diseases, cancer, inflammation and autoinflammation diseases by use in extracorporeal photopheresis, extracorporeal photo immune therapy, extracorporeal photo chemotherapy and cellular therapies. Class 10 Medical device, namely, therapeutic medical device for extracting blood from the body, separating blood, treating it extra corporally, and returning it to the body, used for extra corporeal photopheresis, extra corporeal photo immune therapy, extra corporeal photo chemotherapy, and cellular therapies. Class 42 Pharmaceutical research services; pharmaceutical products development. Class 44 Medical and pharmaceutical consultation; medical services relating to extra corporeal photopheresis, extra corporeal photo immune therapy, extra corporeal photo chemotherapy, and cellular therapies. |
| (540) | METAVIVO THERAPEUTICS |
| (550) | Word |
| (730) |
Therakos, LLC
|
Find out more about publications on the About page.